null Skip to main content

✨ Buy more, save 5% Ends

Acute Leukemias VIII

Acute Leukemias VIII

$105.85
(No reviews yet) Write a Review
Physical book delivery

Shipping calculated at checkout.

Estimated delivery
Adding to cart… The item has been added
Product Details
Author:
B. Wormann
Publisher:
Springer
Publication Date:
Mar 26, 2001
Number of pages:
756 pages
Binding:
Hardback or Cased Book
ISBN-10:
3540411232
ISBN-13:
9783540411239

Overview

Mechanisms of Chromosomal Translocation Breakpoints.- Hematologic Malignancies Following Organ Transplantation.- Molecular Cytogenetic Characterization of a Critical Region in Bands 7q35-q36 Commonly Deleted in Malignant Myeloid Disorders.- olecular Characterization of the Translocation (10;11)(pl3;ql4): MLL and CALM are Fused to AF10 in Morphologically Different Subsets of Acute Leukemia.- LL-Duplcations are Rare and Associated with Poor Prognosis in Acute Myeloid Leukemia.- Real-Time RT-PCR for the Detection and Quantification of AML1/MTG8 Fusion Transcripts in Patients with t(8;21) Positive AML.- Combined Cytogenetic, FISH and RT-PCR Technique in Detection of t(15; 17) and Monitoring of Minimal Residual Disease in Acute Promyelocytic Leukemia.- RT-PCR in Diagnostics and Monitoring of Acute Myeloid.- Chromosome Aberrations in Primary and Secondary Acute Myeloblastic Leukemia.- Are there Two Main Categories of de Novo Acute Myeloid Leukemias with a Normal Karyotype?.- Asynchronous Expression of AC133 on CD34-Negative Leukemic Blast Cells in Childhood B-Cell Precursor ALL.- Expression of AC133 in Childhood Acute Leukemia.- CD10 Expression in T-Lineage Adult Acute Lymphoblastic Leukemia.- Acute Lymphoblastic Leukemia in Childhood with an Unusual Immunophenotype(CD7+/CD56+/CD33+).- Expression of IGFBP-rP2/CTGF is Specific for Malignant Lymphoblasts of Children with Acute Lymphoblastic Leucemia (ALL).- NM23-H1 Protein Expression as a New Prognostic Factor in Acute Lymphoblastic Leukemia.- Monitoring of Wilms' Tumor Gene Transcription in Leukemia Patients.- Effect of Mutationally Activated Ras on the Ras to MAP Kinase Signaling Pathway and Growth Inhibition of Myeloid Leukemia Cells by Inhibitors of the MAP Kinase Cascade.- C-Jun is a JNK-Independent Coactivator of the PU.1 Transcription Factor.- CD7+ and CD56+ Acute Myelogeneous Leukemia is a Distinct Biologic and Clinical Disease Entity.- The Role of Apoptosis in the Course of Acute Leukemia in Children.- Evaluation of Spontaneous and Therapeutically Induced Apoptosis in Childhood Leukemias.- Involvement of BCL-2 and Bax in the IL-7-Induced Inhibition of Spontaneous Apoptosis in Childhood T-ALL.- Analysis of the Apoptotic Signal Transduction Cascade and New Differentially Expressed Genes in Drug Resistant and Sensitive Hematopoetic Cell Lines.- Transforming Activity of Flt3 in 32D Cells.- Evidence of Angiogenesis in Acute Myeloid Leukemia.- Significance of AC133 and CD34 Expression on Acute Myeloid Leukemia Cells.- Heterogeneity in the Stem Cell Compartment of Newly Diagnosed.- Acute Myeloid Leukemia Analyzed by 4-Colour Immunofluorescence Validation of the IPSS and Other Scoring Systems in Patients with Primary MDS.- Although Patients with AML and Complex Aberrant Karyotype Can be Subdivided Into Different Subtypes by Cytogenetics, Prognosis is Equally Poor.- Pharmacokinetics of Idarubicin: Intracellular Events and Extracellular Concentrations.- Oral Idarubicin in Maintenance Therapy of Acute Myeloid Leukemia.- Phase I Study of Liposomal Daunorubicin (DaunoXome) in Relapsed and Refractory Acute Myeloid Leukemia.- Multi Centre Study of a Combination of Fludarabine Phosphate, Cytosine Arabinoside and Granulocyte Colony Stimulating Factor (FLAG) in Relapsed and Refractory Acute Myeloid Leukaemia and in De Novo RAEB-t.- Modulation of AraC by Fludarabine: Results of Salvage Therapy by AMLCG.- Colony Stimulating Factors in Myelodysplastic Syndromes.- Modulation of Ara-C Toxification by Fludarabine and Hydroxyurea in Leukemia Blasts.- Drug Monitoring of Doxorubicin in Children.- Pharmacokinetics of Daunorubicin Entrapped in Liposomes or Erythrocytes - Phase II Study in Refractory Acute Leukemias.- Drug Monitoring During Maintenance Therapy in Children with ALL.- Modulation of Glucocorticoid Resistance in Childhood Acute Lymphoblastic Leukemia; Preliminary Results.- In-Vitro Cellular Drug Resistance in Acute Non-Lymphoblastic.- Leukemia: Comparisons Between Adults and Children Progn...


  • | Author: B. Wormann
  • | Publisher: Springer
  • | Publication Date: Mar 26, 2001
  • | Number of Pages: 756 pages
  • | Binding: Hardback or Cased Book
  • | ISBN-10: 3540411232
  • | ISBN-13: 9783540411239

Reviews

0 Reviews

Write a Review

No reviews yet.

Share your experience and help another reader choose their next book.

Discover your next great book

Get new releases, reader favourites, and special offers delivered to your inbox.